Opioid Epidemic: HHS-OIG’s Crackdown on Treatment Gaps

The opioid epidemic rages on, devastating communities across the nation with its relentless toll. The Department of Health and Human Services Office of Inspector General (HHS-OIG) is determined to combat this crisis head-on.

Recent audits by HHS-OIG have exposed critical gaps in care for Medicare and Medicaid patients battling opioid use disorder. Despite notable progress in Massachusetts, where treatment programs are meeting federal and state standards, there’s still work to be done.

Curtis M. Roy, Regional Inspector General for Audit Services, highlights the importance of addressing this epidemic: ‘Our goal is to enhance care, prevent fraud and abuse, and ultimately improve health outcomes for individuals and communities impacted by this crisis.’

The severity of the situation is underscored by Miriam G. Anderson, a subject matter expert on opioids, who states, ‘Opioid-related overdose deaths claim tens of thousands of lives each year. To help address this crisis, we must ensure that everyone who needs treatment for opioid use disorder has access to it.’

Unfortunately, HHS-OIG’s research reveals that only 18 percent of Medicare enrollees with opioid use disorder receive medication to treat their disorder. Louis A. Day, a team leader and Social Science Research Analyst, emphasizes the need for improved access to Medications for Opioid Use Disorder (MOUD): ‘Access concerns persist in both Medicare and Medicaid programs, leaving many individuals without adequate treatment options.’

While New Jersey is praised for its compliance with federal regulations through its Opioid State Targeted Response (STR) and State Opioid Response (SOR) grants, the ongoing efforts to tackle this epidemic are far from over. HHS-OIG remains committed to improving care and saving lives in the face of this overwhelming crisis.